World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
30176
World Ranking
10140
National Ranking
144

Overview

Núria Malats is affiliated with the Spanish National Cancer Research Centre in Spain. Their research primarily focuses on medicine, with significant contributions to biochemistry, genetics, and molecular biology.

The scientist's work spans various subfields including oncology, surgery, molecular biology, cancer research, and pulmonary and respiratory medicine. Their main research topics cover pancreatic and hepatic oncology research, cancer genomics and diagnostics, bladder and urothelial cancer treatments, epigenetics and DNA methylation, cancer immunotherapy and biomarkers, urinary and genital oncology studies, as well as pancreatitis pathology and treatment.

They have published numerous papers in leading scientific venues. Frequent publication venues include:

  • Pancreatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Gut
  • European Urology
  • Cancer Epidemiology Biomarkers & Prevention

Notable recent papers include:

  • An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer, 2021, Nature Communications
  • A faecal microbiota signature with high specificity for pancreatic cancer, 2022, Gut
  • Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study, 2022, Gastroenterology
  • A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study, 2020, PLoS Medicine
  • FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?, 2020, European Urology

Frequent co-authors include:

  • Francisco X. Real
  • Evangelina López de Maturana
  • Alfredo Carrato
  • Lola Alonso
  • José Perea

Best Publications

  • A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

    Aurélie Kamoun;Aurélien de Reyniès;Yves Allory;Yves Allory;Gottfrid Sjödahl

  • Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

    Mónica Gumá;Ana Angulo;Carlos Vilches;Natalia Gómez-Lozano

  • NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

    Montserrat García-Closas;Núria Malats;Debra Silverman;Mustafa Dosemeci

  • Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools

    Cristina M. Villanueva;Kenneth P. Cantor;Joan O. Grimalt;Nuria Malats

  • Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research

    Richard D. Riley;Jill A. Hayden;Ewout W. Steyerberg;Karel G. M. Moons

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder

  • Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

    Jakob Hedegaard;Philippe Lamy;Iver Nordentoft;Ferran Algaba

  • EphB receptor activity suppresses colorectal cancer progression

    Eduard Batlle;Julinor Bacani;Harry Begthel;Suzanne Jonkeer

  • A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

    Nathaniel Rothman;Montserrat Garcia-Closas;Nilanjan Chatterjee;Nuria Malats

  • Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

    F Graus;J Dalmou;R Reñé;M Tora

  • Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas

    Silvia Hernández;Elena López-Knowles;Josep Lloreta;Manolis Kogevinas

  • P53 as a prognostic marker for bladder cancer: a meta-analysis and review

    Núria Malats;Aurelia Bustos;Cristiane M Nascimento;Francisco Fernandez

  • Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage

    Miquel Porta;Xavier Fabregat;Núria Malats;Luisa Guarner

  • Epidemiology of urinary bladder cancer: from tumor development to patient's death.

    Cristiane Murta-Nascimento;Bernd J. Schmitz-Dräger;Maurice P. Zeegers;Gunnar Steineck

  • Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

    Brian M. Wolpin;Cosmeri Rizzato;Peter Kraft;Charles Kooperberg

  • Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

    Cristina Balbás-Martínez;Ana Sagrera;Enrique Carrillo-de-Santa-Pau;Julie Earl

  • Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.

    Yves Allory;Willemien Beukers;Ana Sagrera;Marta Flández

  • A degradation-sensitive anionic trypsinogen ( PRSS2 ) variant protects against chronic pancreatitis

    Heiko Witt;Miklós Sahin-Tóth;Olfert Landt;Jian Min Chen

  • Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study

    Lee E Moore;Ruth M Pfeiffer;Cristina Poscablo;Francisco X Real

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Meredith Yeager;Weiyin Zhou;Sholom Wacholder

Frequent Co-Authors

Francisco X. Real
Francisco X. Real Pompeu Fabra University
Alfredo Carrato
Alfredo Carrato University of Alcalá
Debra T. Silverman
Debra T. Silverman National Institutes of Health
Manolis Kogevinas
Manolis Kogevinas Pompeu Fabra University
Nathaniel Rothman
Nathaniel Rothman National Institutes of Health
Montserrat Garcia-Closas
Montserrat Garcia-Closas National Institutes of Health
Stephen J. Chanock
Stephen J. Chanock National Institutes of Health
Graham G. Giles
Graham G. Giles University of Melbourne
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Mustafa Dosemeci
Mustafa Dosemeci National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine goes beyond traditional medical school. Today, a range of online degrees provide flexible alternatives to support various roles in healthcare. For those interested in preventative care and wellness, consider one of the best online nutrition programs, which can lead to careers in dietetics, public health, or education.

If you are passionate about healthcare administration and leadership, cahme accredited mha online programs offer a pathway to management roles in hospitals and health systems.

Registered nurses seeking career advancement can benefit from rn to bsn programs that do not require clinical hours. These programs help deepen skills, improve patient outcomes, and open doors to broader nursing opportunities.

Those aiming for the highest level of nursing practice may opt for the shortest post master's dnp program. Earning a Doctor of Nursing Practice can lead to advanced clinical or leadership roles in healthcare.

Online degrees can address different career goals, offering flexibility for working professionals and diverse entry points into the dynamic field of medicine and healthcare.

Best Scientists Citing Núria Malats

Trending Scientists

Recently Published Articles